Dr. Alemozaffar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3430 E La Palma Ave
Anaheim, CA 92806Phone+1 714-644-7111
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2012 - 2014
Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 2008 - 2012- Brigham and Women's HospitalResidency, Surgery, 2007 - 2008
David Geffen School of Medicine at UCLAClass of 2007
Certifications & Licensure
CA State Medical License 2013 - 2025
GA State Medical License 2014 - 2020
MA State Medical License 2007 - 2012- American Board of Urology Urology
Clinical Trials
- Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease Start of enrollment: 2017 Mar 01
Publications & Presentations
PubMed
- 14 citationsTreatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technologyRobert Steven Gerhard, Dattatraya Patil, Yuan Liu, Kenneth Ogan, Mehrdad Alemozaffar
Urologic Oncology. 2017-05-01 - 467 citationsAn intra-tumoral niche maintains and differentiates stem-like CD8 T cellsCaroline S. Jansen, Nataliya Prokhnevska, Viraj A. Master, Martin G. Sanda, Jennifer W Carlisle
Nature. 2019-12-19 - 113 citationsCD8T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.Nataliya Prokhnevska, Maria A Cardenas, Rajesh M Valanparambil, Ewelina Sobierajska, Benjamin G Barwick
Immunity. 2023-01-10
Press Mentions
Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Makes It Easier to See the Invisible in Cancer SurgeryDecember 17th, 2020
Debating the True Benefit of Adjuvant TKIs in High-Risk RCCOctober 4th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
